| 000 | 01526 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513204744.0 | ||
| 264 | 0 | _c20000531 | |
| 008 | 200005s 0 0 eng d | ||
| 022 | _a0882-8245 | ||
| 024 | 7 |
_a10.1089/vim.2000.13.49 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDrulak, M W | |
| 245 | 0 | 0 |
_aVaccination of seropositive subjects with CHIRON CMV gB subunit vaccine combined with MF59 adjuvant for production of CMV immune globulin. _h[electronic resource] |
| 260 |
_bViral immunology _c2000 |
||
| 300 |
_a49-56 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdjuvants, Immunologic |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 |
_aCytomegalovirus _ximmunology |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _ximmunology |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization Schedule |
| 650 | 0 | 4 | _aNeutralization Tests |
| 650 | 0 | 4 | _aPolysorbates |
| 650 | 0 | 4 | _aSqualene |
| 650 | 0 | 4 | _aVaccination |
| 650 | 0 | 4 |
_aViral Envelope Proteins _ximmunology |
| 650 | 0 | 4 |
_aViral Vaccines _xadverse effects |
| 700 | 1 | _aMalinoski, F J | |
| 700 | 1 | _aFuller, S A | |
| 700 | 1 | _aStewart, S S | |
| 700 | 1 | _aHoskin, S | |
| 700 | 1 | _aDuliege, A M | |
| 700 | 1 | _aSekulovich, R | |
| 700 | 1 | _aBurke, R | |
| 700 | 1 | _aWinston, S | |
| 773 | 0 |
_tViral immunology _gvol. 13 _gno. 1 _gp. 49-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/vim.2000.13.49 _zAvailable from publisher's website |
| 999 |
_c10686709 _d10686709 |
||